Statin Intolerance Cardiovascular Disease Study

This study will assess whether administration of an oral investigational medication reduces the risk of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are unable to tolerate statin therapy.

Patients aged 18-85 years old may qualify to receive investigational medication (active drug or placebo). Length of participation may vary but is expected to be about 45 months. Study participants will visit the study centre about 11 times and have about 6 phone visits during this period.

Call the study centre near you, or register now.

Learn more about
Coronary Artery / Peripheral Artery Disease
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Similar Studies

  • At this time there are no other studies for this condition. Please register to be contacted about upcoming studies for this condition.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more